InnovativeBioresearchCoin (INNBC)

[nonsocosa]

Token address: 0x85558055812f19eB084B8bA327470e84Ad795b11 Full name: InnovativeBioresearchCoin Symbol: INNBC Decimals: 8

Issuer's official website: https://www.innovativebioresearch.com

Description: The INNBC Token is issued by the biotech company Innovative Bioresearch Ltd for developing novel AIDS cure research and a decentralized database for clinical data. In addition, the Token is spendable to buy classic iconic JDM cars and is therefore backed by the value of actual physical goods.

A link to the official contract address confirmation: https://www.innovativebioresearch.com/pre-ico

Please scroll the page down, where you can see the Token address reported in the "TOKEN DISTRIBUTION" pharagraph

Links to third-party reviews or discussion of the token, the project/product, or the token issuer:

1. Youtube reviews

Russian language

https://www.youtube.com/watch?v=b74vb5zjq7E

​https://www.youtube.com/watch?v=I2KUAyxpQwM

https://www.youtube.com/watch?v=ktPXafMlLmE

​https://www.youtube.com/watch?v=EeKpIVSsRkQ

https://www.youtube.com/watch?v=KGR36O_ibEM

​https://www.youtube.com/watch?v=5KIJhzIcoSU

​https://www.youtube.com/watch?v=P2rhFOidtyA

​https://www.youtube.com/watch?v=N6oGd9o9Epg

​https://www.youtube.com/watch?v=hwMn5WKgEQI

​https://www.youtube.com/watch?v=7SnQuaMtMes

​https://www.youtube.com/watch?v=poyLH8ZKFhU

https://www.youtube.com/watch?v=qAQdVaJlExg

https://www.youtube.com/watch?v=8ETT4wy2HwI

​https://www.youtube.com/watch?v=0nAcpyiee1A

​https://www.youtube.com/watch?v=4g240CCvBio

https://www.youtube.com/watch?v=wRtHe_3EAsY

https://www.youtube.com/watch?v=M3uX2-RXncs

https://www.youtube.com/watch?v=gIfWmCMT2fg

Turkish language

https://www.youtube.com/watch?v=hst5Vc-lJRI

English language

https://www.youtube.com/watch?v=-L0AadkVMfs

https://www.youtube.com/watch?v=NPdXxhlxOoQ

This is one the best and detailed reviews

https://www.youtube.com/watch?v=12DaVGx-UKU

​

2. Review Articles

English

https://myicoreviews.com/innbc-implementing-the-blockchain-to-end-hiv-aids-ii/

https://steemit.com/ico/@themichaelmatch/innovative-bioresearch

https://goldvoice.club/@themichaelmatch/innovative-bioresearch-the-first-ico-by-a-biotech-company-with-the-goal-of-developing/

https://medium.com/@bdfoysalhossain/innovative-bioresearch-5e2cb600c897

https://golos.io/bitcoin/@sofasharikova/innovative-bioresearch-platform-for-support-of-researches-in-the-sphere-searching-ways-treatment-aids-and-cancer

https://steemit.com/blockchain/@nsamir/innbc-innovative-bioresearch

https://steemkr.com/innbc/@bonanza-kreep/innovative-bioresearch-fighting-cancer-and-aids-with-blockchain

https://cryptocoinpravda.com/innovative-bioresearch-the-first-ico-by-a-biotech-company-with-the-goal-of-developing-2.html

http://vionaamaharani.blogspot.com/2018/05/innbcinnovative-bioresearch.html

http://criptoiman.blogspot.com/2018/06/innovative-bioresource-ico.html

https://www.linkedin.com/pulse/innovative-bioresearch-cares-your-well-being-daniel-konugah

Italian

https://profit-hunters.biz/it/innovativo-bioresearch-revolyucionnaya-Baza-klinicheskix-dannyx/

Russian

http://aromatuspeha.ru/biznes-obuchenie/ico-innovative-bioresearch.html

Partnership anouncement with Fixy Network

https://www.ccn.com/sell-your-tokens-loaded-on-gift-cards-and-50-000-for-selected-startup-projects/

Partnership anouncement with the French electronic giant Archos https://www.archos.com/corporate/press/press_releases/EN_PR_ARCHOS_Innovative_Bioresearch_20180709.pdf

[freeatnet]

Thank you for your request, @nonsocosa! We'll review it as soon as we can. In the meanwhile, here's what to expect:

• Please make sure your request follows the required format and that the information provided is complete and accurate. This will improve the speed of processing your request greatly.
• Keep an eye on this issue. We will post all follow-up and additional questions here.
• You will receive a notification once your request has been reviewed for completeness and accepted.
• You will receive another notification when the token you requested is about to be added, along with the date when it is added.

Please note:

• Adding a token to ForkDelta Tokenbase is free, we do not charge for this service. If you receive any messages asking for payment, do not respond to them.
• We will not send or accept email or direct messages related to token addition requests.

[Philipinho]

There is only one token holder. Last token interaction was 49 days ago.

[nonsocosa]

Hello. We are the Innovative Bioresearch Team. This is because the crowdsale smart contract will be finalized only Today, June 20, 2018, at 22pm CEST time. Only then, reserved Tokens will be distributed and Tokens will be movable out of the wallet. So you will see that, starting from the 20th of June, 2018, at 22pm CEST time, Tokens will begin to be distributed to investors and bounty participants. So we would like to have our Token listed in order for them to trade it on your exchange. I'll post another update once Token distribution has started.

[nonsocosa]

Hello, we started Token distribution and as you can see now there are multiple token holders.

[nonsocosa]

Hello, all requirements are there for the Token to be listed; lots of independent, third parties reviews, and more than 30 Token holders.

Could you please review the listing as soon as possible? We are distributing the Token and the community want to be able to trade it as a listed Token on your exchange.

Many Thanks, Innovative Bioresearch Ltd.

[nonsocosa]

Hello, any update please?

[freeatnet]

@nonsocosa Please clean up your request to match the required format: https://raw.githubusercontent.com/forkdelta/tokenbase/master/.github/ISSUE_TEMPLATE/add-a-new-token.md

[nonsocosa]

Done. Cleaned up the opening post. All information is there for the Token to be listed; lots of independent, third parties reviews, and more than 40 Token holders.

Could you please review the listing as soon as possible?

Thanks.

[nonsocosa]

Hello, can you please speed up the process? I understand you have many coins to review, but our community is huge, we have 100k+ Telegram memebers, and people is waiting for the Token to be listed,

https://t.me/innovativebioresearch

Many Thanks.

[nonsocosa]

Hello, any update?

[nonsocosa]

When are you going to assign someone to our case?

[Philipinho]

Hi @Nonsocosa, you have to be patient. @Freeatnet is currently stacked with many other issues and I'm not available to assist ATM. Thank you.

[nonsocosa]

Token has been listed on IDEX already. If you don't have enough people you should hire more because this is a very unefficient way to handle things.

[nonsocosa]

I am adraid it's going to take ages before the token is listed here. In the meantime, the Token has been added to another exchange. And It took only one day for the TokenStore team to add the coin to their decentralized exchange.

[nonsocosa]

Any update? Any way we can contribute to speed up the process?

[therealMikkoK]

Issues;

1. Clearly inflated user base on TG. ~100.000 members, only ~150 wallets
2. Whitepaper is unclear what the token is for
3. Token economy model makes little sense R1 👎

Needs another opinion @freeatnet @bobbypaintsstuf

[bobbypaintsstuf-zz]

I agree with your 3 points - there exists a nissan skyline - is its value divisable over all the tokens -the white paper indicates the tokens can buy JDM (japan domestic market ) cars - how? from where ? The originator of the InnovativeBioreaserch company Jonathan Fior owns the car - he writes research projects of scientific merit but i dont see how these things are tied together. Token sales raise funds for research - currently 133 wallet holder. the coin is listed on idex - no buy offers and only 9 trades since 20/7/18 not currently listed on CMC

R1 👎

[nonsocosa]

Hello, as you seem to lack a clear understanding of our project, please let me clarify the misinformation.

Issues; Clearly inflated user base on TG. ~100.000 members, only ~150 wallets

You are missing the fact that we launched a very succeessfull airdrop (2 airdrops, one voting airdrop for sato exchange, and a self drop, actually), and that it is still going so airdrop Tokens still have to be distributed to the more than 150k+ people who participated. So no, the numbers are not inflated, it is just that we still have to distribute airdrop tokens. Once airdrop tokens are distributed, there will be more than 150k+ wallets holding the Token. Airdrop/bounty Tokens will be distributed when we manually checked and verified all accounts to eliminate all fake members who joined the airdrop. It’s a lot of work as we have to check more than 150k accounts. So it takes time.

Whitepaper is unclear what the token is for Token economy model makes little sense R1 👎 Needs another opinion @freeatnet

There's a plethora of third party independed reviews starting otherwise. This is just an example

https://www.youtube.com/watch?v=12DaVGx-UKU

The youtuber has no issue at all understanding the whitepaper, even the finest details related to our HIV cure research. So ether she is incredibly smart, or you have a serious lack of cognitive abilitie. Or, you just don't care about reviewing the project, and didn't even took the time to actually read the whitepaper, showing a total lack of respect for the hard work of our team.

Also, as we are dealing with anonymous people here, we would like to know what are your professional qualifications to make such a bold statement. Are you a qualified scientist or economist? Are you in the positionn to be able to understand/judge the token economy model of a project based on biomedical research?

We believe the exact opposite. We believe the WP is clean and clear about what the token is for and the economy model makes perfect sense. Behind our project there are many years of hard work and investments to perform and publish our research. Investors with us know that they are investing into something real and concrete, and not in one of those bubble soap projects that disappear the day after the ICO because they are not solving any real issue and are just a collection of fancy presentations. Our research is very valuable and is a real asset backing the value of the coin, unlike for other coins that are backed by nothing, essentially. Now, Dr. Jonathan Fior is a qualified research scientist with a public record of scientific publications, which can be checked on pubmed:

Fior J. An Initial In Vitro Investigation into the Potential Therapeutic Use of SupT1 Cells to Prevent AIDS in HIV-Seropositive Individuals. PLoS ONE. 2012;7(5):e37511. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22701517

Fior J. Is a pacific coexistence between virus and host the unexploited path that may lead to an HIV functional cure? Viruses. 2013;5(2):753-7. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23430684

Fior J. Salamander regeneration as a model for developing novel regenerative and anticancer therapies. J Cancer. 2014;5(8):715-9. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25258653

Fior J. SupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice. Vaccines. 2016;4(2):13. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27128948

The project is based on biomedical research, and thus it requires specific knowledge to be understood. Lacking the proper set of tools (e.g., academic/specific expertise in the field) can easily lead to superficial/uncomplete/flawed analysis that is not representative for the quality of the project.

We also have a solid corporate partner, the multinational Electronic French company Archos (http://www.archos.com/it/home.html), a company quoted on Nasdaq, who partnered with us for the promotion of their hardware wallet devices. They believe in our business model, which means it is not unclear for the executive officers of a notable company.

https://www.archos.com/corporate/press/press_releases/EN_PR_ARCHOS_Innovative_Bioresearch_20180709.pdf

Thanks.

[nonsocosa]

I agree with your 3 points - there exists a nissan skyline - is its value divisable over all the tokens -the white paper indicates the tokens can buy JDM (japan domestic market ) cars - how? from where ?

This is a completely wrong assumption, indicating that you do not seem to have read the whitepaper. Our company is already partnering with car importers from Japan and Jonathan Fior himself has been involved in the activity of importing JDM cars for years. So we will just sell the cars directly from our JDM online garage shop that will be launched soon. We will give the opportunity to use the Tokens as a means of payment for purchasing the cars.

The originator of the InnovativeBioreaserch company Jonathan Fior owns the car - he writes research projects of scientific merit but i dont see how these things are tied together.

As explained in the whitepaper, he is involved in several type of activities, one of which being JDM car imports. He is very well known in the car community. Just go and check his facebook. We believe that providing such a straightforward utility (i.e., you can directly use our Token to buy physical goods as you would with a fiat currency) can seriously help reaching those customers who are not normally into the crypto world. The car enthusiast community is one of the most welcoming and sensitive community when it comes to supporting social issues such as fighting AIDS. Therefore, we believe that having classic iconic JDM cars also backing the value of INNBC Tokens is true to the spirit of this project, which is to solve a serious global health problem. In addition, the automotive industry is something very responsive and therefore we believe in possible future productive partnerships for further expanding our Token economy, making it constantly growing and successful.

Token sales raise funds for research - currently 133 wallet holder.

Token distribution is not finished yet. Airdrop/bounty Tokens will be distributed when we manually checked and verified all accounts to eliminate all fake members who joined the airdrop. It’s a lot of work as we have to check more than 150k accounts. So it takes time. We also have a self drop going.

the coin is listed on idex - no buy offers and only 9 trades since 20/7/18 not currently listed on CMC

Clearly, we first need to list on a big centrazlied exchange that has a critical mass of users that will help create demand for the token when fundamentals and technicals are pointing for higher prices.

Update: as of today, 27/082018, there have been 94 trades and there are 10 buy offers on IDEX. The Token is growing. Surely, not thanks for you.

[bobbypaintsstuf-zz]

Hello nonsocosa - It was not anticipated that today's comments would "trigger" you to such a rapid and defensive response. Therefore I am taking the time to explain a few points for you.

I can understand that you may feel impatient, frustrated and I will presume under pressure however NO coin has a right to receive a listing from ForkDelta and as such it is at Your request that this listing is being considered.

The project has applied to this exchange for listing and therefore your application has now reached the stage of verification of the validity of the information and the project overall, as I hope you will appreciate that involves actual people checking the actual information and today 2 people independently looked at the project for the first time and concluded at this time they could not recommend listing. several concerns were raised - some of which you have answered in your response.

If I may be so bold as to ask you to edit your responses into a coherent and respectful addition to your application please.

Please also treat all the people you deal with and the application process with respect and where questions or concerns are raised please provide as much information as you can as you are ultimately helping yourself by helping the people involved to understand your project. Simply put it is your job to convince 2 sceptical strangers that they have nothing to be sceptical about so much so that they could be confident to invest as ultimately by championing your listing they will effectively be saying to the users of FD that they have that level of confidence in your project.

It is important to FD to be selective about which projects are accepted for listing and any legitimate project must be comprehensibly shown to be so. As I am sure you are aware this industry has a darker less reputable side both from projects and exchanges and FD is as keen as your project should be for it to be seen as part of the change away from those aspects.

As a bio research company, scrutiny, attention to detail and reputation are as much intricately entwined in your success as those attributes are in ours. scepticism of claims is as healthy and necessary in the "cryto" world as the bio research sphere. If this is different from the other exchanges you have dealt with that is because FD is different and proud to be so.

Presuming you intend to continue this process then going forward you can expect more questions seeking clarification regarding any concerns or lack of clarity in understanding your project.

In the meantime rather than suggesting FD seek all of the information about how this project will function perhaps you would oblige to provide the information in advance instead.

We would especially like to understand the tokenomics of your project, the life cycle of a coin and verifiable proof of all the entities involved in that system please.

[nonsocosa]

Hello nonsocosa - It was not anticipated that today's comments would "trigger" you to such a rapid and defensive response. Therefore I am taking the time to explain a few points for you.

We were very suprised by total lack of professionality in your review of our project. I must admint that at first we thought those comments were from some random users spreading misinformation about our project. This is why our response was defensive. But it seems the bar is set very low here so maybe we should have had lowered our expectations.

I can understand that you may feel impatient, frustrated and I will presume under pressure however NO coin has a right to receive a listing from ForkDelta and as such it is at Your request that this listing is being considered.

We are not impatient/frustrated as we never relied on the listing on FD as something important for our project. And it surely is in your power to abuse your position to list tokens on the basis of personal reasons/random criteria. But you are not doing your community any favour.

The project has applied to this exchange for listing and therefore your application has now reached the stage of verification of the validity of the information and the project overall, as I hope you will appreciate that involves actual people checking the actual information and today 2 people independently looked at the project for the first time and concluded at this time they could not recommend listing. several concerns were raised - some of which you have answered in your response.

The extremely superficial review of our project did not show any respect for the hard work of our team. And we are wondering why you ask for independ third party reviews as they are completely ignored.

If I may be so bold as to ask you to edit your responses into a coherent and respectful addition to your application please.

We edited our response, but you really should consider that if you want respect you have to give respect. And as I pointed out, with the extremely superficial/flawed review of our project you did not show any respect for the hard work of our team.

Please also treat all the people you deal with and the application process with respect and where questions or concerns are raised please provide as much information as you can as you are ultimately helping yourself by helping the people involved to understand your project. Simply put it is your job to convince 2 sceptical strangers that they have nothing to be sceptical about so much so that they could be confident to invest as ultimately by championing your listing they will effectively be saying to the users of FD that they have that level of confidence in your project.

The problem is that your selection criteria seem pretty random and not following any quality standard. You are confident about supporting fake/scam projects such as the CHUCK NORRIS COIN, and it should not be our job to convince you that supporting scam projects is not positive for your community. Furthermore, a much more wiser apporach would be to look at the independent, third parties reviews of the project to have an unbiased opinion, instead of asking us to convince you about the quality of the project. And we say this going against our own interests.

It is important to FD to be selective about which projects are accepted for listing and any legitimate project must be comprehensibly shown to be so.

I am not sure which part of this applied to the listing of coins such as CHUCK NORRIS COIN on FD. I read that "His white paper consists of 2 pages. The first page is just a blank sheet with only his name on it ('nuff said), while the second page consists of a list of cryprocurrencies that he will allow to survive." As I said before, your selection criteria seem pretty random to say the least, and not following any quality standard .

As I am sure you are aware this industry has a darker less reputable side both from projects and exchanges and FD is as keen as your project should be for it to be seen as part of the change away from those aspects.

There is a fundamental lack of projects based on something solid and concrete in the crypto world. The large majority of the coins on the market are backed by no real assets, no real business. By contrast, our biomedical research is a real and very valuable asset, which is backing the value of the Token. We are a biotech company developing novel biomedical research in the field of HIV, cancer and regeneration research. This makes a substantial difference with regard to the intrinsic value of the Token and its potential for growing. For instance, as we develop new pharmaceutical producs and generate revenue, the Token should appreciate consequently. And because we will accept the Token as a means of payment for all our future medical services and treatments, the Token will be directly backed by the commercial value of our research. And as we raise more funds by selling our coin, those funds are further invested into developing new research, which in turn will increase the value of the INNBC Token.

Speaking of our research, given the importance and novelty of our AIDS cure research, the news of the publication of our pioneering pilot study exploring SupT1 cell infusion therapy for HIV in humanized mice has been reported by more than 230 international news outlets such as Yahoo! Finance, Reuters, Bloomberg, MarketWatch, Boston Globe, Seeking Alpha, Wichita Business Journal, Milwaukee Journal Sentinel, News9.com, Wall Street Online Germany, and Medical News Today among many others, resulting in the study ranking among the top 5% of all research outputs tracked by Altmetric (https://mdpi.altmetric.com/details/6965770#score)

After dealing with your random selection criteria for adding coins, we are surely more aware now why this industry has a darker and less reputable side.

As a bio research company, scrutiny, attention to detail and reputation are as much intricately entwined in your success as those attributes are in ours. scepticism of claims is as healthy and necessary in the "cryto" world as the bio research sphere. If this is different from the other exchanges you have dealt with that is because FD is different and proud to be so.

It is important to understand that scientific research is something serious. The peer review process is very rigorous and this ensure that only high quality research is accepted for publication. For instance, our latest research paper entitled “SupT1 Cell Infusion as a Possible Cell-Based Therapy for HIV: Results from a Pilot Study in Hu-PBMC BRGS Mice”( http://www.mdpi.com/2076-393X/4/2/13) was published in the jornal “Vaccines” (http://www.mdpi.com/journal/vaccines). Vaccines is a member of the Committee on Publication Ethics (http://publicationethics.org/). Vaccines is part of the MDPI network, which takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. To verify the originality of content submitted to the journals, they use iThenticate to check submissions against previous publications. MDPI works with http://publons.com/ to provide reviewers with credit for their work.

Even if you are proud of FD policy, let me assure you that the scientific community has much more rigorous standards when it comes to peer review for scientific studies. So I would like to stress the fact that all our work is easily verifiable by checking our scientific publications from the NIH government database pubmed (https://www.ncbi.nlm.nih.gov/pubmed). Unlike you, we do not hide behind anonymity.

And you are saying to be proud to list fake/scam projects such as CHUCK NORRIS COIN to FD without any issue, while at the same time denying the request for a legit project such as INNBC that is working to develop a cure for AIDS. Honestly, it's baffling how you can be proud of such a policy. We would find such a policy extremely detrimental to the reputation of any exchange. You are not doing your community any favour.

Surely, the lack of regulation for decentralized exchanges encourages this kind of misbehaviour.

Presuming you intend to continue this process then going forward you can expect more questions seeking clarification regarding any concerns or lack of clarity in understanding your project.

In the meantime rather than suggesting FD seek all of the information about how this project will function perhaps you would oblige to provide the information in advance instead.

We would especially like to understand the tokenomics of your project, the life cycle of a coin and verifiable proof of all the entities involved in that system please.

Even if all the information you are asking is explained in great detail in the white papers, I will do my best to try to summarize it in the following paragraph. The project is very articulated and involves many different aspects.

First, let's recap the main features of the project.

-First ICO launched by a Biotech company for funding a low cost AIDS cure solution to allow access to the treatment where access to traditional costly HIV antiretroviral treatment is hampered by social and/or economic limitations. Because although we are a for profit company, we also have a conscience.

-Creation of the first decentralized database for storing and processing clinical data, with an application designed by a research scientist to ease the process of performing biomedical research. The blockchain provides some specific features that make it an ideal technology for scientific data, such as immutability (to form a permanent record), decentralization (to be publicly shared), and high security (smart contracts are almost impossible to compromise).

-The "You're not alone" app will provide a social platform for HIV seropositive people to follow the research, discuss it, and find information and support about their condition. We hope to create a large community where HIV seropositive people can stand together and not feel alone in their battle against AIDS. As an incentive, INNBC Tokens will be rewarded to members who make particularly useful contributions; furthermore, INNBC Tokens will also give access to moderation roles, allowing to earn from in-app ads.

-The INNBC Token will be spendable to buy wonderful iconic JDM cars such as Nissan Skylines, Toyota Supras, Subaru Imprezas and Mitsubishi Evolutions from the INNBC JDM ONLINE GARAGE that will be launched right after the Token sale, offering amazing deals and worldwide shipping. We wanted to protect INNBC investors from the highly speculative nature of trading prices on crypto exchanges by having our Token backed by the value of actual physical goods; these classic JDM cars are true collector items and as such they are only going up in value.

Let's then analyze them in greater detail

•At the first stage (shortly after the end of the Token Sale) we will launch our INNBC JDM ONLINE GARAGE, were INNBC tokens can be spent to buy cars from a selection of high quality JDM classic cars. Selection of cars will mostly concentrate on classic iconic JDM cars such as Skylines, Supras, Subaru, and EVOs. Wonderfully, when it comes to JDM cars, our founder, Jonathan Fior, has a great expertise as he is personally involved in the business of importing them and over the years he has therefore established a solid network of professional contacts, which makes us confident about providing a quality service.

•At the second stage (6 months after Token sale) we plan to launch the first version of our “You’re not alone” app, providing on one hand a decentralized database for processing clinical data, and on the other hand a social platform for the HIV seropositive community to access our future services.

The INNBC token will be spendable to access a number of privileged features in the app ecosystem such as becoming moderator in the social communities. The 1% of the revenue generated by in-app ads will go to community moderators as a compensation for their work. So you will be able to use our Token to become moderator, and once you have such a position, you will earn actual money from in-app ads as a compensation for your work.

In addition, Token economy will be integral part of the rep reward point system of the social community. Users who will make particularly useful contributions will earn Tokens. As an incentive to make the community grow, which in turn means more revenue from in app-ads, and thus more earings for moderators.

Let’s explain why we named the application “You’re not alone”. The application will also document the progress of our AIDS cure research project, featuring periodic updates such as articles, vlogs. This will create a community where HIV seropositive people can stay up to the date, comment, share, interact with us working on the cure, and with each others. Something that creates a bridge between HIV seropositive people and us research scientists working on the cure. Something that allows the HIV seropositive community and anyone interested to be part of this journey. Something that can send the message that they are not alone in their battle. That we are fighting for them. That we care about them. A message of hope. Our vision and intention is therefore to create an application that will also act as a social app for HIV seropositive people to participate and create new topics and discussions to support each others and stand together in the fight against AIDS. Discussions will be moderated by a team of moderators, and qualified physicians will also participate in the community for providing expert medical advice as a free service to the users.

The application will also provide information about all the ongoing clinical trials, how to participate, and once the treatment is approved, it will provide information about the clinics and hospitals offering the treatment, and how to make appointments with legit clinicians that are officially collaborating with us.

So, what is the main factor that will drive the user adoption of our app, which in turn will make the community grow, meaning more revenue from in app-ads? Our AIDS cure research. HIV seropositive people (and anyone who is just interested about AIDS research) will join the community to be updated about the state of our research, to open topics discussing the research, and for receiving information and support by our staff that will manage the platform. In conclusion, our AIDS research will be integral to the utilty and therefore value of INNBC Tokens.

The "you're not alone" app will also feature a decentralized database for processing clinical data. The app will feature a user-friendly interface allowing any clinician running a clinical investigation to enter the data produced by their trials. The application would allow the input of a broad range of individual parameters for each treated patient, such as age, ethnicity, disease progression stage, viral tropism of HIV virus carried, along with the clinical protocol used (e.g., dosage of SupT1 cells infused each week) and the outcome of the treatment (e.g., viral load, CD4+ T cell count). The app would then access and elaborate the data on the fly; statistical analysis (means, standard deviations, correlations, power) and even the elaboration of suggested treatment profiles that could work best for each type of patient could be performed. This would take away the burden of having to manually search and process all the data as in the current centralized databases. And such an application would have an infinite potential for growing. For instance, an amazing feature could be to store in the database the genotypic information of the HIV virus carried by each patient, allowing to keep track of all mutations and genetic modifications caused by the treatment as well as the resulting viral phenotypic changes. Therefore, such a database would be constantly growing and evolving as new parameters are added to it, and it would be always available, anytime, anywhere, and to anyone connected. Such an app would help speed up tremendously the clinical development stages of our AIDS cure research; it could be a game changer.

We will start using the app for our own research, which means any user will be able to download the app and have a representation of all the data on the fly. Something that current ancient databases cannot provide. And it is likely that our app will also be used by other research institutions as we believe that it will help speed up clinical research development tremendously.

Why exactly do we need blockchain technology for the purpose of storing clinical data? Couldn't we just build a well secured database that is fast to search in using a traditional centralized platform?

​There are several good reasons actually.

•Immutability. Scientific data need to be immutable. Once a study is peer reviewed and published, its data must be permanently stored and never altered. In the blockchain, all data is stored in every single node, never ceasing to exist, and always staying on the blockchain. It is immutability that gives the blockchain its openness and BFT (Byzantine Fault Tolerance).

​•Decentralization. The blockchain is designed to be distributed and synchronized across networks, making data freely available to anyone. We believe that scientific data should be shared and not being hidden behind a firewall.

​•Security. The kind of transactions that can be performed are strictly defined in advance and stored in the blockchain as “smart contracts”; this prevents fraudulent data from being added to the blockchain thus ensuring integrity of the database. By contrast, it would be much easier to compromise a centralized database.

​In conclusion, although it is true that such an application could be implemented with a centralized system, decentralization is the only way to ensure the data is not manipulated, and all information is pubblicly available in a platform that can't be influenced by the will of any particular entity or government. Decentralization is essential to hand over administrative authority from central institutions managing the data, such as governments and private entities, to the collectivity. In fact, if the database is controlled by one single entity, being it a private entity or government, it means that such entity has total control over the database, and such control can be influenced by personal conflicts of interests. Therefore, decentralization is the only way to ensure that scientific data become public property. In addition, in terms of costs, creating an infrastructure ensuring the same level of data integrity protection of a smart contract deployed on the Etherum blockchain, which is basically impossible to compromise, and most importantly, maintaining such a platform up and running, would simply not be feasible.

Notably, we also plan to accept INNBC Tokens as a means of payment for all our future medical treatments and products.

There were 36.7million people infected by HIV globally in 2016, 17.5million of which were left untreated, according to UNAIDS. Our mission is to develop a low cost cell-based therapy solution for HIV to allow access to the treatment for those individuals who are normally left untreated due to social and/or economic limitations. We estimate our treatment to be significantly cheaper than antiretroviral therapy (ART), which is the conventional drug-based therapy for HIV, and substantially cheaper than any gene therapy product using modified autologous cells offered by our competitors.

With a potential target of 36.7million HIV infected individuals globally, we estimate our AIDS cure solution could generate 9billion/year in revenue by successfully targeting 20% of the global HIV infected population, which if our therapy will prove to be safe and effective as an HIV cure we believe is a realistic goal. We believe this is a very straightforward business model, which should not be very hard to understand.

[therealMikkoK]

Although both medical research and motor vehicles are important, after much thought we have come to the unfortunate conclusion that we shall not add your token INNBC to ForkDelta at this time. This issue is possible for re-opening in the future, once you have established either one of the two main businesses. We wish you and your team all the best in your efforts, which in them selves are applaudable. Sincerelly, ForkDelta Team. @freeatnet @bobbypaintsstuf

[nonsocosa]

Hello,

We are reopening the issue because the research business has already been established since 2014, when the company was first founded in Italy.

The undeniable evidence proving that we are conducting this business is that in 2016 we published the first results of the preclinical animal research that we are actively performing to develop SupT1 cell infusion therapy, our novel cell-based therapy for HIV.

As you may not be aware of this, when a biotech/pharmaceutical company is developing a new therapeutical/pharmaceutical product, there are three main stages the research goes through.

1)Preclinical research using in vitro models of the disease, in our case HIV infection.

2)Preclinical animal research using in vivo animal model of the disease, in our case HIV infection.

3)Human trials, which are in turn classified in stage 1, 2, and 3 trials. This is the last step before the pharmaceutical product can be approved for human therapy.

I'll copy below the press release announcing the publication of the first results of our preclinical animal research.

Innovative Bioresearch Announces Publication of Pioneering Pilot Study Exploring SupT1 Cell Infusion as a Cell-Based Therapy for HIV in Humanized Mice

Innovative Bioresearch Nov 21, 2016, 06:01 EST

MILAN, April 26, 2016 /PRNewswire/ --

Innovative Bioresearch announced today the publication of a pioneering pilot study in the MDPI journal Vaccines (http://www.mdpi.com/2076-393X/4/2/13), in which a novel cell-based HIV therapy using the SupT1 cell line as a decoy target for HIV-1 was explored, for the first time, in an in vivo animal model.

Innovative Bioresearch Announces Publication of Pioneering Pilot Study Exploring SupT1 Cell Infusion as a Cell-Based Therapy for HIV in Humanized Mice Innovative Bioresearch Announces Publication of Pioneering Pilot Study Exploring SupT1 Cell Infusion as a Cell-Based Therapy for HIV in Humanized Mice As observed in a previous in vitro study performed by the same author, Jonathan Fior, who conceived this innovative approach, when primary CD4+ T cells are infected with HIV in the presence of SupT1 cells, the preferential infection of SupT1 cells can spare primary CD4+ T cells from infection and depletion. Accordingly, a possible approach to cure HIV could be represented by the strategy of infusing irradiated SupT1 cells into the patient to move HIV infection toward the inoculated cells, which should prevent infection and depletion of the patient's own CD4+ T cells and, therefore, AIDS.

For testing in vivo this potential HIV therapy, Hu-PBMC BRGS mice were chosen as animal model and experiments were performed by state-of-the-art service company AXENIS (www.axenis.fr). The animals were infected with a high input of HIV-1 LAI followed by weekly SupT1 cell infusions as an HIV treatment over a 4-week study period. Analysis of the results revealed some interesting tendencies in the generated data, such as significantly lower viral replication (~10-fold) and potentially preserved CD4+ T cell frequency at Week 1 in all animals treated with SupT1 cell infusion. Of note, one animal exhibited a sustained decrease in HIV replication and CD4+ T cell depletion (no virus detected anymore at Weeks 3 and 4), a result that may hold the key to future HIV treatments.

As explained in Jonathan Fior's papers, SupT1 cells have been shown to have a very powerful vaccination effect in vitro. Upon prolonged replication in these cells, the HIV virus evolves toward a less virulent phenotype with a reduced capacity for syncytium formation and a higher sensitivity to neutralization, and most notably it adapts so well to replicate in SupT1 cells that it gradually loses the ability to replicate in normal cells. This phenomenon could harbor a significant therapeutic potential that could be exploited with SupT1 cell infusion therapy. Owner of Innovative Bioresearch, Jonathan Fior is the leading research scientist in exploring this novel therapeutic approach.

SOURCE Innovative Bioresearch

https://prn.to/2lB77j7